Prove cliniche Nct
Clinical Trial Results:
Dosisfindungsstudie für Sugammadex und Neostigmin zur Reversierung einer geringen neuromuskulären Restblockade (train of four ratio 0,2) [Sugammadex and Neostigmine dose finding study for reversal of residual neuromuscular blockade at a train of four ratio of 0.2]
| Summary | |
EudraCT number | 2009-013499-29 |
Trial protocol | DE |
Global completion date | 30 Nov 2011 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 24 Jul 2020 |
First version publication date | 24 Jul 2020 |
Other versions | |
Summary report(s) | Pub_SUNDRO20 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.